The results showed that ATR treatment induced ferroptosis in breast cancer cells compared to the control by increasing iron levels, promoting MDA accumulation, increasing the amount of ROS, ensuring GSH depletion, and also modulating the expression levels of genes and proteins involved in the ferroptosis pathway. This evidence concerns the gene ATR and breast carcinoma.